A Study In Healthy Subjects Of Single Doses of PF-05230901 Injected Under The Skin

A Phase 1 Ascending Single Dose Study To Evaluate The Safety, Tolerability, And Pharmacokinetics Of PF-05230901 Administered Subcutaneously To Healthy Subjects

This study will examine whether a single dose of PF-05230901 is safe and well tolerated when given to healthy volunteers by injection under the skin. An additional objective is to measure the blood concentrations of PF-05230901. Each dose will be tested in a different group of subjects starting from the lowest dose.

Inclusion Criteria:

• Healthy subjects

Exclusion Criteria:

• History of seizures, including childhood seizures.
• History of movement disorders or related neurological conditions.
• History of head trauma associated with loss of consciousness.